Navigation Links
Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles

s, and the combination therapy was as well tolerated as Oxaliplatin treatment alone. This study supports further evaluation of ON 01910.Na and the combination with Oxaliplatin in additional clinical trials in patients with liver, hormone refractory prostate and melanoma tumors (abstract 2271).

An oral presentation, "Phase I study of ON 01910.Na, A Novel Cell Cycle Inhibitor in Adult Patients with Solid Tumors by A. Jimeno, J. Li, M.V.R Reddy, E.P Reddy, A. Chan, X. Zhang, P. Kulesza, J. Wheelhouse, G. Cusatis, A. Howard, M. Maniar, W.A Messersmith, D. Laheru, M. Rudek, S. D. Baker, M. Hidalgo, and R. C. Donehower, summarizes the Phase I study conducted at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medical Center, Baltimore, MD, in which ON 01910.Na has shown preliminary signs of clinical activity early in development. ON 01910.Na has also evidenced significant preclinical activity against a novel direct pancreatic cancer xenograft model. A gene expression-based assay identifies tumors likely to respond to ON 01910.Na, and will be tested in a Phase II clinical study in pancreatic cancer patients. Integrating early clinical and preclinical development programs is an efficient way to generate rationale for disease-directed studies and biomarkers (oral presentation in a "Breakthroughs in Clinical Research" session on Monday).

Additional scientific studies employing Onconova Therapeutics, Inc., anticancer compounds being presented at this meeting include: "Mass Spectrometric Study of Antibody Drug conjugates" by J. Roboz, S.Y. Cho, S. C. Bell, Glenn J. Fegley, J. L. Duke, S. C. Cosenza and J. F. Holland (abstract 920); "Mass Spectrometric Study of Drug Bound to Protein" by S.Y. Cho, J. Roboz, T. Ohnuma and J. F. Holland (abstract 3182); and "Evaluation of ON 01910.Na, a novel modulator of PLK-1 pathway and development of a cyclin B1 based predictive assay in pancreatic cancer" by A. Jimeno, A. Chan, G. Cusatis, X. Zhang, J. Wheelhouse, A
'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:7/23/2014)... -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical ... in opioid antagonists, announced today that it has ... respect to its naloxone-based opioid overdose reversal nasal ... received an additional commitment from the National Institute ... Institutes of Health ("NIH"), to fund a second ...
(Date:7/23/2014)... July 23, 2014 This September leading clinicians ... Las Vegas for DOCtalk 2014 ... author, forward thinker and private practitioner Dr. David ... to candidly discuss clinical and practice management efficiency and ... a unique opportunity to welcome fresh thinking and join ...
(Date:7/23/2014)... 23, 2014 Global healthcare company ... facing currency headwinds, increased price competition and supply disruptions ... Andrew Witty points out that the company is very ... reason to be confident about long-term prospects as well ... CFO Simon Dingemans adds that ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 32014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
(Date:7/23/2014)... (July 23, 2014) Statins, a class of drugs ... patient,s risk of developing Barrett,s esophagus, according to a ... , the official journal of the American Gastroenterological Association. ... with statin use. , "Patients who received statins had ... Barrett,s esophagus compared to non-users," said study author Hashem ...
(Date:7/23/2014)... With cloud storage fast replacing traditional ... LeaseQ announced that that despite the lack of ... still see robust growth in computer hardware and ... technology equipment leasing, visit:, https://www.leaseq.com/computer-equipment-leasing , ... quoted as saying, “Although the growth of server ...
(Date:7/23/2014)... Hill, FL (PRWEB) July 23, 2014 The ... percent reduction in prescription drug deaths from 2010 to 2012. ... infamous for its minimal monitoring of access to some of ... the wrong hands. Florida’s law enforcement launched an initiative ... now nearly nonexistent compared to the 65 that existed in ...
(Date:7/23/2014)... 23, 2014 On July 21, 2014, My ... advocate Jack Tracey for an episode that spoke about the ... Deierlein asks Tracey to talk some about the formation of ... its mission, it was started right here in Charleston, originally ... was to help survivors of sexual abuse. Their purpose has ...
(Date:7/23/2014)... Five years ago, when the SSM St. ... options for babies diagnosed with a medical condition before birth. ... country for innovative fetal therapies. Since then, nearly 1,000 families ... for their babies in the womb, and the team has ... “A number of the babies we see are facing life-threatening ...
Breaking Medicine News(10 mins):Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 3Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 2Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 3Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 4Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2Health News:St. Louis Fetal Care Institute Marks Five Years of Life Changing Care and Fetal Surgery 2
... flu at the weekend, taking the death toll in the country ... said Monday . ,Indonesia has seen its toll from ... confirmed human deaths occurred here. ,"A boy who died ... positively infected," Ningrum, from the ministry's National Bird Flu Information Centre, ...
... Dengue fever killed 30 people in Myanmar in the first six ... latest country in the region to experience a surge in ... ministry official, told the weekly Myanmar Times newspaper that the number ... of this year there have been about 3,000 cases of the ...
... milk into a skin-care product that would wipe away wrinkles ... ,The government's team of camel researchers, which has already ... has found cosmetic properties in the hardy mammal's milk. ... to a hospital's skin department to study it on 20 ...
... demonstrated conclusively that a specific protein and its signaling ... essential to the creation and repair of the brains ... mouse models points the way to developing treatments or ... repair in children and adults. The paper will be ...
... make real breakthroughs in childrens medicine if they include children ... ,Professor John Warner was speaking today at the opening of ... to paediatric clinical research. ,The unit is run ... and it is based next to the hospitals paediatric wards ...
... Biology Laboratory (EMBL) and the University of Michigan have ... kidney disease ,In the current online ... the gene cause nephronopthisis (NPHP) in humans and mice. ... childhood that leads to kidney failure requiring organ transplantation. ...
Cached Medicine News:Health News:Indonesia Confirms 81st Bird Flu Death 2Health News:Specific Protein is Instrumental in Myelination 2Health News:Specific Protein is Instrumental in Myelination 3Health News:Experts Need to Include Children in Research 2Health News:New Therapies for Kidney Diseases 2
2 mm wide x 3 mm long, with rounded triangular tip. Angled 45 degrees. Hexagonal handle....
5.5 pointed curved blade. Octagonal handle....
3 mm curved blade. Round handle....
8 mm downcutting Royce blade. Angled shaft. 60 mm from angle to tip....
Medicine Products: